Abstract
The inhibitory and relaxant effects of the L-type calcium antagonists nifedipine, nimodipine, verapamil and diltiazem, and of the T-type calcium antagonist mibefradil, on contractions of isolated human detrusor muscle were investigated. The tissue was obtained from 10 patients undergoing cystectomy due to bladder cancer. Effects of the calcium antagonists at different concentrations on the concentration-response curves for carbachol were investigated. Furthermore, concentration-relaxation curves were performed using potassium-precontracted muscle strips. All L-type calcium antagonists suppressed the mean concentration-response curve of carbachol significantly at a concentration of 10−6 M. Mibefradil up to 10−5 M did not significantly suppress it. Nifedipine significantly reduced the carbachol-induced maximum contraction to 75% and 44%, verapamil to 75% and 67% of the appropriate control value at concentrations of 10−7 and 10−6 M, respectively. Diltiazem reduced it insignificantly to 96% and 71% at the above-mentioned concentrations. The concentration-relaxation experiments revealed following pD2-values and maximum relaxations of nifedipine, nimodipine, verapamil and diltiazem, respectively: 6.23, 6.37, 5.66, 5.81 and 85%, 83%, 82%, 90%. Maximum relaxations and pD2-values were not significantly different from each other. The lowest concentration, for which a significant effect compared to control in Student`s t-test was found, amounted to 10−10 M, 10−9 M, 10−7 M, 10−6.5 M and 10−4 M for nimodipine, nifedipine, diltiazem, verapamil and mibefradil, respectively. L-type calcium antagonists are very potent relaxant agents of the human detrusor muscle in vitro.
Similar content being viewed by others
References
Hockerman GH, Peterson BZ, Johnson BD, Catterall WA (1997) Molecular determinants of drug binding and action on L-type calcium channels. Annu Rev Pharmacol Toxicol 37:361–396
Bernink PJLM, Prager G, Schelling A, Kobrin I (1996) Antihypertensive properties of the novel calcium antagonist mibefradil (Ro 40-5967): a new generation of calcium antagonists? Hypertension 27:426–432
Karam H, Clozel JP, Bruneval P, Gonzalez M-F, Ménard J (1999) Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. Hypertension 34:673–678
Krayenbuhl JC, Vozeh S, Kondo-Oestreicher M, Dayer P (1999) Drug-drug interactions of new active substances: mibefradil example. Eur J Clin Pharmacol 55:559–565
Abernethy DR, Schwartz JB (1999) Calcium-antagonist drugs. N Engl J Med 341:1447–1457
Tsien RW, Lipscombe D, Madison DV, Bley KR, Fox AP (1988) Multiple types of neuronal calcium channels and their selesctive modulation. Trends Neurosci 11:431–438
Huguenard JR (1996) Low threshold calcium currents in central nervous system neurons. Annu Rev Physiol 58:329–348
Perez-Reyes E (2003) Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83:117–161
Wegener JW, Schulla V, Lee T-S, Koller A, Feil S, Feil R, Kleppisch T, Klugbauer N, Moosmang S, Welling A, Hofmann F (2004) An essential role of Cav1.2 L-type calcium channel for urinary bladder function. FASEB J 18:1159–1161
Hu T (2004) Costs of urinary incontinence and overactive bladder in the United States: a comparative study. Urology 63(3):461–465
Andersson K-E (2000) Mode of action of alpha1-adrenoreceptor antagonists in the treatment of lower urinary tract symptoms. BJU Int 85(Suppl 2):12–18
Yarker YE, Goa KL, Fitton A (1995) Oxybutynin. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic use in detrusor instability. Drugs Aging 6(3):243–262
Kay GG, Granville LJ (2005) Antimuscarinic agents: implications and concerns in the management of overactive bladder in the elderly. Clin Ther 27(1):127–138
Furukawa T, Nukada T, Miura R, Ooga K, Honda M, Watanabe S, Koganesawa S, Isshiki T (2005) Differential blocking action of dihydropyridine Ca2+ antagonists on a T-type Ca2+ channel (alpha1G) expressed in Xenopus oocytes. J Cardiovasc Pharmacol 45(3):241–246
De Paoli P, Cerbai E, Koidl B, Kirchengast M, Sartiani L, Mugelli A (2002) Selectivity of different calcium antagonists on T- and L-type calcium currents in guinea-pig ventricular myocytes. Pharmacol Res 46(6):491–497
Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA (2000) Mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 295:302–308
Strege PR, Bernard CE, Ou Y, Gibbons SJ, Farrugia G (2005) Effect of mibefradil on sodium and calcium currents. Am J Physiol Gastrointest Liver Physiol [Epub ahead of print]
Elliott RA, Norman RI, Parker SG, Whitaker RP, Castleden CM (1996) Effect of treatment with calcium antagonists in vitro and in vivo on the contractile response of isolated rat and human detrusor muscle. Clin Sci (Lond) 91(4):467–474
Schneider T, Fetscher C, Krege S, Michel MC (2004) Signal transduction underlying carbachol-induced contraction of human urinary bladder. J Pharmacol Exp Ther 309(3):1148–1153
Masters JG, Neal DE, Gillespie JI (1999) The contribution of intracellular Ca 2+ release to contraction in human bladder smooth muscle. Br J Pharmacol 127:996–1002
Kajioka S, Nakayama S, McMurray G, Abe K, Brading AF (2002) Ca(2+) channel properties in smooth muscle cells of the urinary bladder from pig and human. Eur J Pharmacol 443:19–29
Sui GP, Wu C, Fry CH (2003) A description of Ca2+ channels in human detrusor smooth muscle. BJU Int 92(4):476–482
Sui GP, Wu C, Fry CH (2001) Inward calcium currents in cultured and freshly isolated detrusor muscle cells: Evidence of a T-type calcium current. J Urol 165:621–626
Hashitani H, Brading AF (2003) Electrical properties of detrusor smooth muscles from the pig and human urinary bladder. Br J Pharmacol 140:146–158
Andersson K-E, Fovaeus M, Morgan E, McLorie G (1986) Comparative effects of five different calcium channel blockers on the atropine-resistant contraction in electrically stimulated rabbit urinary bladder. Neurourol Urodyn 5:579–86
Diederichs W, Sroka J, Graff J (1992) Comparison of Bay K 8644, nitrendipine and atropine on spontaneous and pelvic-nerve-induced bladder contractions on rat bladder in vivo. Urol Res 20(1):49–53
Sjogren C, Andersson KE (1979) Effects of cholinoceptor blocking drugs, adrenoceptor stimulants, and calcium antagonists on the transmurally stimulated guinea-pig urinary bladder in vitro and in vivo. Acta Pharmacol Toxicol (Copenh) 44(3):228–234
Naglie G, Radomski SB, Brymer C, Mathiasen K, O’Rourke K, Tomlinson G (2002) A randomized, double-blind, placebo controlled crossover trial of nimodipine in older persons with detrusor instability and urge incontinence. J Urol 167:586–590
Rud T, Andersson KE, Ulmsten U (1979) Effects of nifedipine in women with unstable bladders. Urol Int 34:421–429
Bödeker J, Salim SA, Nagel R (1976) Wirkungen von Nifedipin bei urologischen Patienten. Dtsch med Wschr 101:1866–1868
Kato K, Kitada S, Chun A, Wein AJ, Levin RM (1989) In vitro intravesical instillation of anticholinergic, antispasmodic and calcium blocking agents (rabbit whole bladder model). J Urol 141(6):1471–1475
Hassouna M, Nishizawa O, Miyagawa I, Toguri A, Gotoh M, Elhilali M (1986) Role of calcium ion antagonists of the bladder detrusor muscle: in vitro and in vivo study. J Urol 135(6):1327–1331
Gotoh M, Kondo A, Mitsuya H (1987) Inhibitory effect of a calcium entry blocker (verapamil) on detrusor muscle contractility: feasibility of clinical application. Hinyokika Kiyo 33(3):357–363
Mattiasson A, Ekstrom B, Andersson KE (1989) Effects of intravesical instillation of verapamil in patients with detrusor hyperactivity. J Urol 141(1):174–177
Acknowledgements
We are grateful to Prof. Peter Alken and Dr. Maurice Stephan Michel (Mannheim, Germany) for giving the opportunity to do research. We are grateful to Mr. Joachim Brade (Mannheim, Germany) for statistical advice. This work was supported by the Juniorforschungsfond of the Faculty of Clinical Medicine Mannheim, Germany.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Badawi, J.K., Li, H., Langbein, S. et al. Inhibitory effects of L- and T-type calcium antagonists on contractions of human detrusor muscle. Eur J Clin Pharmacol 62, 347–354 (2006). https://doi.org/10.1007/s00228-006-0100-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00228-006-0100-8